Ricardo Capone: Pioneering Technological Solutions in the Cannabis Industry

Ricardo Capone, the Chief Technology Officer (CTO) of Dr Green, emerges as a key figure in the intersection of technology and the cannabis industry. His journey is marked by a relentless pursuit of excellence, innovation, and a commitment to revolutionizing the way cannabis is regulated and accessed globally.

Dr Green, a medical cannabis facility based in Portugal, has been at the forefront of bio-technology and research into cannabis use for patients for the past five years. Under Capone’s leadership, the company is set to launch a groundbreaking digital token that empowers holders to transact cannabis globally.

At the core of Dr Green’s innovation is a seed-to-sale traceability system designed by Capone and his team. This system utilizes cryptographic encoding to track the genetic sequence of cannabis plants through every stage of their lifecycle. From cultivation to distribution, key metrics such as lighting information, temperature, humidity, and chemical balance are recorded, providing consumers with a transparent and verifiable history of the cannabis they purchase.

One of the notable highlights of Capone’s career is his recognition as Business Man Of The Month in 2018, a testament to his accomplishments and contributions to the business world.

However, Capone’s journey has not been without challenges. One of the most formidable obstacles he faced was tackling the issue of spoofing cannabis, a problem rampant in the industry. Through innovative use of genetic coding, Capone and his team have developed a system that promises to eliminate criminal activity from the legal cannabis supply chain.

Capone’s wisdom extends beyond technological innovation to the power of collaboration and visionary leadership. He emphasizes the importance of surrounding oneself with the right people, citing the inspirational vision of Dr Green’s CEO, Maximillian White, as integral to their success.

Looking ahead, Capone envisions Dr Green becoming a regulatory standard in the cannabis industry. With a pilot program spanning three years, the company aims to collect data globally to demonstrate the effectiveness of their technology in eliminating criminal activity. Ultimately, Capone plans to expand Dr Green’s regulatory standards from Portugal to the EU and beyond.

Source: USAWIRE